These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 24806621

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 63. MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition.
    Wu X, Xi X, Yan Q, Zhang Z, Cai B, Lu W, Wan X.
    Med Oncol; 2013 Dec 28; 30(4):751. PubMed ID: 24158756
    [Abstract] [Full Text] [Related]

  • 64. Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
    Cheng Y, Jiang S, Yuan J, Liu J, Simoncini T.
    Gynecol Endocrinol; 2018 Oct 28; 34(10):853-858. PubMed ID: 29658350
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.
    Zhang H, Zhang Z, Wang S, Zhang S, Bi J.
    Biomed Pharmacother; 2018 Jun 28; 102():626-632. PubMed ID: 29602130
    [Abstract] [Full Text] [Related]

  • 67. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.
    Chen Y, Song Y, Mi Y, Jin H, Cao J, Li H, Han L, Huang T, Zhang X, Ren S, Ma Q, Zou Z.
    Apoptosis; 2020 Apr 28; 25(3-4):205-216. PubMed ID: 31938895
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J, Kong X, Li J, Luo Q, Li X, Shen L, Chen L, Fang L.
    Oncol Rep; 2014 Mar 28; 31(3):1357-63. PubMed ID: 24366472
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Role of CXCR7 and effects on CXCL12 in SiHa cells and upregulation in cervical squamous cell carcinomas in Uighur women.
    Kurban S, Tursun M, Kurban G, Hasim A.
    Asian Pac J Cancer Prev; 2014 Mar 28; 15(21):9211-6. PubMed ID: 25422203
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X, Zhen P, Niu X, Dai Y, Wang Y, Zhou M.
    J Dermatol Sci; 2020 Oct 28; 100(1):67-74. PubMed ID: 32951990
    [Abstract] [Full Text] [Related]

  • 78. [Role of miR-155 in invasion and metastasis of lung adenocarcinoma A549 cells].
    Cheng TL, Hu CP, Li M, Gu QH, An J.
    Zhonghua Zhong Liu Za Zhi; 2016 Feb 28; 38(2):86-92. PubMed ID: 26899325
    [Abstract] [Full Text] [Related]

  • 79. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
    Li X, Ling N, Bai Y, Dong W, Hui GZ, Liu D, Zhao J, Hu J.
    Anat Rec (Hoboken); 2013 Mar 28; 296(3):427-32. PubMed ID: 23175429
    [Abstract] [Full Text] [Related]

  • 80. miR-187* Enhances SiHa Cervical Cancer Cell Oncogenicity Via Suppression of WWOX.
    Hung PS, Chuang FJ, Chen CY, Chou CH, Tu HF, Lo SS.
    Anticancer Res; 2020 Mar 28; 40(3):1427-1436. PubMed ID: 32132039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.